Cyclophosphamide as a Treatment for Focal Segmental Glomerular Sclerosis Recurrence in a Kidney Transplant Patient

BACKGROUND Primary focal segmental glomerular sclerosis (FSGS) frequently causes recurrence after kidney transplantation, leading to graft loss in half of the patients. Conservative treatment of FSGS is the main acceptable method due to the lack of randomized clinical trials. A few strategies are kn...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The American journal of case reports 2021-02, Vol.22, p.e929097-e929097
Hauptverfasser:	Al-Jehani, Mariann H, Al-Husayni, Faisal, Aljabri, Abdullah, AlMaghraby, Hatim Qasim, Banamah, Turki A
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Child Cyclophosphamide - therapeutic use Female Glomerulosclerosis, Focal Segmental - drug therapy Humans Kidney Transplantation Recurrence Sclerosis Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!